HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Correlation of newborn hemolytic disease with ABO antibodies in sera of pregnant women].

Abstract
To investigate the relations between morbidity of hemolytic diseases of newborn and ABO antibodies (HDN) in sera of Han and Yao nationality, pregnant women were examined before and after delivery. Antibodies screen, direct antiglobulin test, free antibodies and elution test were all performed. The results indicated that immunologic ABO antibodies of Han people were found in 673 cases out of 1,471 Han pregnant women, and was also found in 28 cases out of 65 Yao pregnant women, and there was no significant difference of incidences between Han and Yao nationality. 31 cases of HDN were found out of 288 newborn in Han and 3 cases of HDN were found out of 25 newborn in Yao, and there was no significant difference between Han and Yao nationalities. The characteristics of HDN in Han nationality were as same as in Yao nationality. In conclusion, the morbidity of HDN in Han and Yao nationalities of Shaoguan area did not showed essential difference, the immunologic ABO antibodies and its titration test, especially, elution test are important for prognosis of HDN.
AuthorsShao-Ming Yang, Qiao-Ying Wu, Hong-Qing Luo, Jiong-Cai Lan
JournalZhongguo shi yan xue ye xue za zhi (Zhongguo Shi Yan Xue Ye Xue Za Zhi) Vol. 13 Issue 5 Pg. 875-7 (Oct 2005) ISSN: 1009-2137 [Print] China
PMID16277862 (Publication Type: English Abstract, Journal Article)
Chemical References
  • ABO Blood-Group System
  • Immunoglobulin G
Topics
  • ABO Blood-Group System (immunology)
  • Adult
  • Blood Group Incompatibility (blood, congenital)
  • China
  • Erythroblastosis, Fetal (blood, pathology)
  • Female
  • Humans
  • Immunoglobulin G (blood)
  • Infant, Newborn
  • Male
  • Pregnancy
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: